期刊文献+

Plk1、P53在结直肠腺瘤和瘤癌变组织中的表达及相关关系 被引量:1

Expression of Plk1 and P53 in colorectal adenomas and tumor cancerous tissue and their correlation
下载PDF
导出
摘要 目的研究结直肠腺瘤癌变转化过程中Plk1和P53表达及二者关系。方法采用免疫组织化学MaxVisionTM法检测45份结直肠腺瘤癌变标本中Plk1蛋白和P53蛋白在腺瘤癌变区、重度异型增生区及轻度异型增生区的表达。结果 45例结直肠腺瘤癌变标本中Plk1、P53蛋白在腺瘤癌变区、重度异型增生区及轻度异型增生区的表达分别为77.8%和71.1%,60.0%和64.4%,13.3%和17.8%,癌变和重度异型增生的PlK1和P53阴性表达率与对照组和轻度异型增生比较差异有统计学意义(P<0.01);在癌变区Plk1和P53蛋白表达呈正相关(r=0.603,P<0.01)。结论 Plk1和P53共同参与了结直肠腺瘤癌变的转化过程且关系密切。 Objective To observe the expression of Plk1 and P53 in colorectal adenomas cancerous conversion process and their relationship.Methods The expression of Plk1 and P53 was detected in adenoma cancerous area of 45 cases of colorectal adenomas and tumor cancerous tissue,and in severe atypical hyperplasia area and mild atypical hyperplasia area by MaxVisionTM immunohistochemical method.Results In the adenoma cancerous area,severe atypical hyperplasia area and mild atypical hyperplasia area,the expression rates of Plk1 and P53 were 77.8% and 71.1%,66.7% and 64.4%,13.3% and 17.8% respectively.There were significant differences in the negative expression rate of PlK1t and P53 in adenoma cancerous as well as severe atypical hyperplasia and control group as well as mild atypical hyperplasia(P〈0.01).The expression of Plk1 was positively correlated with that of P53 in tumor cancerous area(P〈0.01).Conclusion Plk1 and P53 are involved in colorectal adenomas cancerous transformation process,which suggests that P53 is a target of Plk1.
作者 陈彦杰
出处 《河北医药》 CAS 2010年第19期2645-2646,共2页 Hebei Medical Journal
关键词 PLK1 P53 结肠直腺瘤 瘤癌变 免疫组化 Plk1 P53 colorectal adenomas cancerous tumors immunohistochemistry
  • 相关文献

参考文献3

二级参考文献36

  • 1刘林,张敏,邹萍,田蕾,刘芳华.PLK1基因沉默对K562/A02细胞周期、增殖和耐药性的影响[J].中国实验血液学杂志,2006,14(2):241-246. 被引量:5
  • 2王立辉,杨静玉,吴春福.胃癌信号转导通路治疗靶点的研究进展[J].中国药理学通报,2007,23(2):147-150. 被引量:11
  • 3熊福银,刘慧远,陈红星,邓继先.丝/苏氨酸蛋白激酶Plk1研究进展[J].中国生物工程杂志,2007,27(5):142-145. 被引量:3
  • 4Watanabe N, Sekine T, Takagi M, et al. Deficiency in chromosome congression by the inhibition of Plkl Polo Box domain-dependent recognition [ J ]. J Biol Chem,2009 ,284 (4) :2344 - 53.
  • 5Walter S A, Cutler R E Jr,Martinez R,et al. StklO, a new member of the polo-like kinase family highly expressed in hematopoietic tissue [ J ]. J Biol Chem, 2003,278 ( 20 ) : 18221 - 8.
  • 6Lowery D M, Lin D, Yaffe M B. Structure and function of Polo-like kinases [ J ]. Oncogene, 2005,24 ( 2 ) : 248 - 59.
  • 7Smits V A, Medema R H. Checking out the G2/M transition[ J ]. Biochim Biophys ,2001,1519 : 1 - 12.
  • 8Casenghi M, Francis A, Erich A. Phosphorylation of Nip by negatively regulates its dynein-dynactin-dependent targeting to the centrosome [ J ]. Cell Sci,2005,118:5101 - 8.
  • 9Prasanth S G, Prasanth K V, Siddiqui K, et al. Human Orc2 localizes to centrosomes, centromeres and heterochromatin during chromosome inheritance[ J]. EMBO J,2004 ,23 ( 13 ) :2651 - 63.
  • 10Stuermer A, Hoehn K, Faul T, et al. Mouse pre-replicative complex proteins colocalise and interact with the cen~osome[ J]. Cell Biol, 2007,86( 1 ) :37 - 50.

共引文献16

同被引文献2

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部